Drug & intervention

oxytocin

RxCUI 7824

Clinical trials52
Recruiting2
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Oxytocin

Oxytocin is a peptide hormone and neuropeptide normally produced in the hypothalamus and released by the posterior pituitary. Present in animals since early stages of evolution, in humans it plays roles in behavior that include social bonding, love, reproduction, childbirth, and the period after childbirth. Oxytocin is released into the bloodstream as a hormone in response to sexual activity and during childbirth. It is also available in pharmaceutical form. In either form, oxytocin stimulates uterine contractions to speed up the process of childbirth. In its natural form, it also plays a role in maternal bonding and milk production. Production and secretion of oxytocin is controlled by a positive feedback mechanism, where its initial release stimulates production and release of further oxytocin. For example, when oxytocin is released during a uterine contraction at the start of childbirth, this stimulates the production and release of more oxytocin and an increase in the intensity and frequency of contractions. This process intensifies in frequency and continues until the triggering activity ceases. A similar process takes place during lactation and during sexual activity. Oxytocin is derived by enzymatic splitting from the peptide precursor encoded by the human OXT gene. The deduced structure of the active nonapeptide is:

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro StudyNCT06285396 · 2024-03-18
RECRUITING
The Role of Oxytocin in Regulating Blood GlucoseNCT06334172 · 2024-01-01
RECRUITING
The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 DiabetesNCT06881459 · 2025-03-25
COMPLETED
The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with ObesityNCT06189001 · 2024-01-01
COMPLETED
Methods Decreasing Bleeding in Open MyomectomyNCT05806307 · 2023-03-15
UNKNOWN
Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid ObesityNCT04902729 · 2021-07-20
COMPLETED
Effects of Oxytocin and Vasopressin on Moral Decision MakingNCT04890470 · 2021-03-02
COMPLETED
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in SchizophreniaNCT03900754 · 2020-01-13
TERMINATED
Pre-operative Intranasal Oxytocin for Enhancing Bariatric-induced Diabetes RemissionNCT05207774 · 2020-01-09
UNKNOWN
A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour InductionNCT03749902 · 2020-01-06
COMPLETED
Neurobiological Effects of Oxytocin in SchizophreniaNCT04177719 · 2019-11-08
UNKNOWN
qMOLI- A Qualitative Assessment of Misoprostol or Oxytocin for Labour InductionNCT04037683 · 2019-10-18
COMPLETED
Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2NCT03957083 · 2019-06-26
COMPLETED
High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour in Obese WomenNCT03604874 · 2018-09-01
COMPLETED
Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible MechanismsNCT03662425 · 2018-07-21
COMPLETED
Differential Effects of Vasopressin and Oxytocin on Attention ControlNCT04715737 · 2017-12-19
COMPLETED
Intranasal Oxytocin for Infants With Prader-Willi SyndromeNCT03245762 · 2017-08-01
COMPLETED
Oxytocin Dosage to Decrease Induction DurationNCT03140488 · 2017-06-05
COMPLETED
Oxytocin HIV Meth StudyNCT02881177 · 2017-01-01
COMPLETED
Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.NCT03081832 · 2017-01-01
COMPLETED
Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 YearsNCT03114371 · 2016-11-28
COMPLETED
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)NCT02221830 · 2015-02-01
COMPLETED
Oxytocin Effects on Food Motivation PathwaysNCT02276677 · 2014-10-01
COMPLETED
Neurobiological Bases of Paternal NurturanceNCT02223429 · 2014-08-01
COMPLETED
Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi SyndromeNCT02804373 · 2014-06-01
COMPLETED
Oxytocin as Adjunctive Therapy for SchizophreniaNCT01699997 · 2014-01-01
COMPLETED
Neurobiological Effects of Oxytocin in Schizophrenia - Imaging StudyNCT04158167 · 2013-09-01
COMPLETED
In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid ObesityNCT01865669 · 2013-05-01
COMPLETED
Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS InfantsNCT02205034 · 2013-05-01
COMPLETED
Oxytocin as Adjunctive Treatment of SchizophreniaNCT01568528 · 2013-03-01
COMPLETED
Adult Study Oxytocin - fMRINCT02566356 · 2012-09-01
COMPLETED
Effects of Intranasal Oxytocin on Satiety Signaling in People With SchizophreniaNCT01614093 · 2012-06-01
COMPLETED
Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective PatientsNCT01598623 · 2012-05-01
UNKNOWN
Oxytocin MEG StudyNCT02568709 · 2012-02-01
COMPLETED
Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe PreeclampsiaNCT01382732 · 2012-01-01
UNKNOWN
Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot StudyNCT01239888 · 2012-01-01
UNKNOWN
Pharmacological Approach to Improve the Outcome of Social Cognition TrainingNCT01517360 · 2012-01-01
COMPLETED
Tolerance of Intranasal Administration of OT in Prader-Willi Newborn BabiesNCT01548521 · 2011-07-01
COMPLETED
Antipsychotic Effects of OxytocinNCT01621737 · 2011-06-01
TERMINATED
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?NCT01312272 · 2011-04-01
COMPLETED

Leading sponsors

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.